Melinta Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
January 03, 2018 07:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial...
Big3Bio Introduces Inaugural Sponsors and Partners of BioWeekSF
December 07, 2017 07:55 ET
|
Big3Bio
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Big3Bio is proud to announce the leading industry organizations that have signed on as inaugural partners and sponsors of BioWeekSF, the site...